VJVirtual | Off-the-shelf TCR-NK: an update

Namir Hassan, PhD, Zelluna Immunotherapy, Oslo, Norway, discusses how the ‘off the shelf’ T-Cell receptor natural killer (TCR-NK) cell therapy can be used to multiple indication. Dr Hassan also discusses the benefits of ‘off the shelf’ TCR-NK cell therapy, such as efficacy, scalability, immediacy and economics. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).